Literature DB >> 2843673

Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection.

K Maier1, P Gabriel, E Koscielniak, Y D Stierhof, K H Wiedmann, B Flehmig, A Vallbracht.   

Abstract

The production of interferon (IFN) during a chromium-51 release assay with hepatitis A virus (HAV)-infected fibroblasts and autologous peripheral blood lymphocytes from patients with acute HAV infection was studied to determine whether IFN plays a role in immunopathogenesis of hepatitis A infection in humans. Skin fibroblasts of eight patients after acute HAV infection and from two control persons without history of current or past HAV infection were infected with HAV. Peripheral blood lymphocytes were collected at different times after the onset of icterus and tested in a chromium-51 release assay against autologous HAV-infected skin fibroblasts for their cytolytic and IFN-producing activity. The IFN produced during the assay was characterized and found to have the properties of human gamma IFN. Cytotoxicity and gamma IFN release were virus specific. The cell types responsible for both functions were characterized and found to be in the HLA-dependent T8+ lymphocyte subset. Considering that gamma IFN has an antiviral effect on persistent HAV infection in vitro and that it probably accounts for stimulation of HLA class I antigen expression on hepatocytes, our experimental results presented here demonstrate that human gamma IFN produced by HAV-specific T cells may participate in pathogenesis of hepatitis A infection in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843673      PMCID: PMC253519          DOI: 10.1128/JVI.62.10.3756-3763.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody responses in vivo and in vitro.

Authors:  J L Virelizier; E L Chan; A C Allison
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

2.  Hepatitis A virus infection and the interferon system.

Authors:  A Vallbracht; P Gabriel; J Zahn; B Flehmig
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

3.  Non-production of interfering substances by serum from patients with infectious hepatitis.

Authors:  P E Taylor; A J Zuckerman
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Failure to detect circulating interferon during acute viral hepatitis.

Authors:  J Rakela; L Ishizawa
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

6.  Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon.

Authors:  L A Lampson; C A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  The pathology of viral hepatitis types A and B in chimpanzees. A comparison.

Authors:  J L Dienstag; H Popper; R H Purcell
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

8.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen.

Authors:  J R Klein; D H Raulet; M S Pasternack; M J Bevan
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells.

Authors:  J F Bukowski; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 2.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

3.  Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA.

Authors:  Kerstin Brack; Iris Berk; Thomas Magulski; Jörg Lederer; Andreas Dotzauer; Angelika Vallbracht
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A.

Authors:  B Fleischer; S Fleischer; K Maier; K H Wiedmann; M Sacher; H Thaler; A Vallbracht
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 5.  Reassessing immune control of hepatitis A virus.

Authors:  Christopher M Walker; Zongdi Feng; Stanley M Lemon
Journal:  Curr Opin Virol       Date:  2015-01-21       Impact factor: 7.090

6.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.

Authors:  Volker Fensterl; Dajana Grotheer; Iris Berk; Stefanie Schlemminger; Angelika Vallbracht; Andreas Dotzauer
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.

Authors:  S Mattioli; L Imberti; R Stellini; D Primi
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 9.  [Hepatitis as a travel disease].

Authors:  J Hadem; H Wedemeyer; M P Manns
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

10.  Using IFN-gamma as a biomarker for detecting exposure to viral pathogens.

Authors:  Lu Li; Alfred P Dufour
Journal:  Curr Microbiol       Date:  2007-10-10       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.